79 Wellington St W, Suite 3000, Box 270, TD Ctr, Toronto, ON
Year called to bar: 1985 (New York); 1989 (Massachusetts)
Cheryl leads the country’s premier life sciences practice. She advises the industry’s largest investors and most innovative start-ups on highly complex transactions worldwide. With an international reputation for quality and helping clients advance their strategies, Cheryl combines deep knowledge of the market with a business-minded practical approach. Cheryl is the leader of Torys’ Life Science practice, a cross-border group in both Canada and the United States. She represents the entire spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers. Cheryl is widely recognized for her long track record of helping life sciences companies at all stages formulate and evolve their domestic and international growth strategies, source capital, and develop and optimize their corporate and tax structures. When clients need transactional counsel in the life sciences sector, Cheryl has extensive experience advising on venture and later-stage financings, IPOs, mergers & acquisitions, licensing transactions and joint ventures or alliances with strategic partners. Prior to joining Torys, Cheryl led the 85-attorney life sciences group of a US law firm.
On July 17, 2017, Norgine B.V., a European specialist pharmaceutical company, acquired all issued and outstanding shares of Merus Labs International Inc. (Merus), pursuant to a plan of arrangement for $1.65 per common share in cash, including the assumption of all debt obligations, for a total enterprise value of approximately $342 million.
On April 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired 18 products from Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l (collectively, Covis). The purchase price of US$1.2 billion was paid in cash at closing.